Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
The DC Cohort Longitudinal HIV Status Neutral Study
for
HIV, AIDS
Location: Washington D.C. DC
Sponsor: George Washington University
Sex: All
Age: 0+
Code: NCT01206920
Recruiting
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
for
HIV Infections, Sexually Transmitted Diseases
Location: Washington DC, Miami FL, San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.
Sex: All
Age: 15+
Code: NCT04855773
Recruiting
New Needle for Two-Needle Hemodialysis
for
End Stage Renal Disease
Location: Washington DC
Sponsor: Biomedical Enterprises Inc
Sex: All
Age: 18 - 70+
Code: NCT01416896
Phase 2, Phase 3, Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for
Carcinoma, Squamous Cell
Location: Washington D.C. DC, Charlottesville VA, Philadelphia PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 60+
Code: NCT04892173
Phase 3, Recruiting
A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: Washington D.C. DC, Manassas VA, Philadelphia PA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07112872
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
for
COVID-19 SARS-CoV-2 Infection
Location: Washington D.C. DC, Silver Spring MD, Columbia MD,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT06679140
Phase 3, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase 3, Recruiting
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Washington D.C. DC, Brooklyn NY, New York NY,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18+
Code: NCT07759128
Phase 3, Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Washington D.C. DC, Columbia MD, Manassas VA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase 3, Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Washington D.C. DC, Baltimore MD, Lancaster PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Washington D.C. DC, Philadelphia PA, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase 2, Recruiting
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
for
Gastroesophageal Adenocarcinoma
Location: Washington D.C. DC, Newark DE, Pittsburgh PA, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07069712
Phase 2, Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Washington D.C. DC, Baltimore MD, Charlottesville VA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management